There are many chemicals used in the pharmaceutical manufacturing process, including buffers, inorganic salts, and stabilizers for the different steps and processes. Another process-limiting challenge is viscosity in manufacturing and formulating highly concentrated process. With those amounts and complicated steps, process efficiency is a key element for bioprocessing. For example, dry granulation can be used to prevent caking of chemicals, and viscosity modifying excipients combinations provide a tailored solution to address raw material handling and enabling high concentrated process like TFF with SP-TFF with improved processability and operator safety.
In this webinar, you will learn:
- What effects clumping and caking of pharmaceutical raw materials can have on operations
- How dry granulation of raw materials can help overcome these issues
- Benefits of viscosity-reducing excipient combinations during TFF process to enable higher concentrated process
Speakers
Kyung-min Shin
Merck
Customer Application Consultant
Kyungmin is customer application consultant at Merck, and is responsible for a broad portfolio of excipients for formulation and process materials. He has more than 19 years experience in the pharma and biopharma industry with different positions in the field of pharmaceutical formulation focusing on the NCE drug products, various IMD projects, biosimilars/vaccine projects, and C&D projects with CDMO/researchers by leading the formulation team as senior formulation researcher in his prior roles.
Chetna Jain
Merck
Senior Technical Application Expert
In her current role as a senior technical application expert at Merck, Chetna spearheads formulation initiatives across South Asia. She has more than 14 years of experience within the pharmaceutical, healthcare, and life sciences sectors, with expertise in product and project lifecycle management, coupled with business development across global markets. A certified project manager, she has also worked at Thermofisher Scientifc, Informa Markets, and IQVIA (global projects for GSK and Novartis).
Pharma and biopharma manufacturing
- Pharma and biopharma manufacturing
Duración:1h 7min
Idioma:English
Sesión 1:presentado September 24, 2024
Para seguir leyendo, inicie sesión o cree una cuenta.
¿No tiene una cuenta?